(Hypertension. 1997;30:905-911.)
© 1997 American Heart Association, Inc.
Articles |
Structure and Function of Small Arteries in Salt-Induced Hypertension
Effects of Chronic Endothelin-Subtype-A–Receptor Blockade
From the Division of Cardiology, Cardiovascular Research, and Division of Hypertension (S.S.), University Hospital, Bern, Institute of Physiology, University Zürich, and Division of Cardiology (T.F.L.), University Hospital, Zürich, (Switzerland).
Correspondence to Thomas F. Lüscher, MD, FACC, FESC, Professor and Head of Cardiology, University Hospital, CH-8091 Zürich, Switzerland. E-mail karluh{at}usz.unizh.ch
Abstract The involvement of endothelin in salt-induced hypertension is unclear. In the Dahl rat model, we studied the effects of a selective endothelin-subtype A (ETA) receptor antagonist, LU135252, on blood pressure, vascular structure, and function. Dahl salt-sensitive and salt-resistant rats were treated for 8 weeks with 4% NaCl alone or in combination with LU135252 taken orally (60 mg/kg per day). The geometry and reactivity of basilar and mesenteric arteries were studied in vitro under perfused and pressurized conditions using a video dimension analyzer. Chronic salt administration increased systolic blood pressure by 37±3 mm Hg and media-lumen ratio of the basilar and mesenteric arteries in salt-sensitive rats (P<.05). These structural changes were caused by eutrophic remodeling in basilar and hypertrophic remodeling in mesenteric arteries. Endothelium-dependent relaxations to acetylcholine and contractions to endothelin-1 were impaired in mesenteric arteries of salt-sensitive rats on a high NaCl diet. LU135252 prevented part of the increase in systolic blood pressure and structural and functional alterations but increased plasma endothelin 1 levels (P<.05 versus salt-treated, salt-sensitive rats). LU135252 had no effect on these parameters in salt-resistant rats. These findings suggest that the long-term pressor effect of salt administration is mediated in part by the action of endogenous endothelin acting via ETA receptors. Thus, chronic ETA receptor blockade may be useful therapeutically to lower arterial pressure and prevent endothelial dysfunction and hypertrophic remodeling of resistance arteries in salt-sensitive forms of hypertension.
Key Words: basilar artery • mesenteric resistance artery • vascular remodeling • endothelin receptors • endothelium-derived relaxing factor • rats, Dahl
This article has been cited by other articles:
 |
|
 |
|
  B. J Epstein Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist Ann. Pharmacother., July 1, 2008; 42(7): 1060 - 1069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Ko, F. Amiri, N. R. Pandey, D. Javeshghani, E. Leibovitz, R. M. Touyz, and E. L. Schiffrin Resistance artery remodeling in deoxycorticosterone acetate-salt hypertension is dependent on vascular inflammation: evidence from m-CSF-deficient mice Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1789 - H1795. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gluais, J. Paysant, C. Badier-Commander, T. Verbeuren, P. M. Vanhoutte, and M. Feletou In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factors Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2255 - H2264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Feletou and P. M. Vanhoutte Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture) Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D'Angelo, J. S. Pollock, and D. M. Pollock In vivo evidence for endothelin-1-mediated attenuation of {alpha}1-adrenergic stimulation Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1251 - H1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D'Angelo, J. S. Pollock, and D. M. Pollock Endogenous endothelin attenuates the pressor response to acute environmental stress via the ETA receptor Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1829 - H1835. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Emre, S Orgul, T Haufschild, S G Shaw, and J Flammer Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma Br J Ophthalmol, January 1, 2005; 89(1): 60 - 63. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Amiri, A. Virdis, M. F. Neves, M. Iglarz, N. G. Seidah, R. M. Touyz, T. L. Reudelhuber, and E. L. Schiffrin Endothelium-Restricted Overexpression of Human Endothelin-1 Causes Vascular Remodeling and Endothelial Dysfunction Circulation, October 12, 2004; 110(15): 2233 - 2240. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. V Agapitov and W. G Haynes Role of endothelin in cardiovascular disease Journal of Renin-Angiotensin-Aldosterone System, March 1, 2002; 3(1): 1 - 15. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Rathaus and J. Bernheim Oxygen species in the microvascular environment: regulation of vascular tone and the development of hypertension Nephrol. Dial. Transplant., February 1, 2002; 17(2): 216 - 221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Sullivan, D. M. Pollock, and J. S. Pollock Altered Nitric Oxide Synthase 3 Distribution in Mesenteric Arteries of Hypertensive Rats Hypertension, February 1, 2002; 39(2): 597 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. QUASCHNING, L. V. D'USCIO, S. SHAW, H.-J. GRONE, F. RUSCHITZKA, and T. F. LUSCHER Vasopeptidase Inhibition Restores Renovascular Endothelial Dysfunction in Salt-Induced Hypertension J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2280 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. AMANN, G. MIL TENBERGER-MIL TENYI, A. SIMONOVICIENE, A. KOCH, S. ORTH, and E. RITZ Remodeling of Resistance Arteries in Renal Failure: Effect of Endothelin Receptor Blockade J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2040 - 2050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Intengan and E. L. Schiffrin Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis Hypertension, September 1, 2001; 38(3): 581 - 587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Krenek, S. Salomone, J. Kyselovic, M. Wibo, N. Morel, and T. Godfraind Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats Hypertension, April 1, 2001; 37(4): 1124 - 1128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Quaschning, F. Ruschitzka, S. Shaw, and T. F. Luscher Aldosterone Receptor Antagonism Normalizes Vascular Function in Liquorice-Induced Hypertension Hypertension, February 1, 2001; 37(2): 801 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Elijovich, C. L. Laffer, E. Amador, H. Gavras, M. R. Bresnahan, and E. L. Schiffrin Regulation of Plasma Endothelin by Salt in Salt-Sensitive Hypertension Circulation, January 16, 2001; 103(2): 263 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. d'Uscio, T. Quaschning, J. C. Burnett Jr, and T. F. Luscher Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE Inhibition Hypertension, January 1, 2001; 37(1): 28 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. A. Paniagua, M. B. Bryant, and J. A. Panza Transient Hypertension Directly Impairs Endothelium-Dependent Vasodilation of the Human Microvasculature Hypertension, December 1, 2000; 36(6): 941 - 944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. D. Intengan and E. L. Schiffrin Structure and Mechanical Properties of Resistance Arteries in Hypertension : Role of Adhesion Molecules and Extracellular Matrix Determinants Hypertension, September 1, 2000; 36(3): 312 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. BARTON, I. VOS, S. SHAW, P. BOER, L. V. D'USCIO, H.-J. GRÖNE, T. J. RABELINK, T. LATTMANN, P. MOREAU, and T. F. LÜSCHER Dysfunctional Renal Nitric Oxide Synthase as a Determinant of Salt-Sensitive Hypertension: Mechanisms of Renal Artery EndothelialDysfunction and Role of Endothelin for Vascular Hypertrophy andGlomerulosclerosis J. Am. Soc. Nephrol., May 1, 2000; 11(5): 835 - 845. [Abstract] [Full Text]
|
|
|
|
|
|
E. L. Schiffrin Role of Endothelin-1 in Hypertension Hypertension, October 1, 1999; 34(4): 876 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Moreau Endothelin in hypertension: A role for receptor antagonists? Cardiovasc Res, September 1, 1998; 39(3): 534 - 542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Matrougui, P. Schiavi, D. Guez, and D. Henrion High Sodium Intake Decreases Pressure-Induced (Myogenic) Tone and Flow-Induced Dilation in Resistance Arteries From Hypertensive Rats Hypertension, July 1, 1998; 32(1): 176 - 179. [Abstract] [Full Text] [PDF]
|
|